LYT-310
Undisclosed
PreclinicalActive
Key Facts
About PureTech Health
PureHealth Health is a biotherapeutics company with a proven track record of translating scientific innovation into clinical and commercial value. It employs a distinctive operational model, acting as a biotech 'studio' that conceives, founds, and advances new companies around specific scientific programs. This approach has generated 29 therapeutic candidates, including three that have progressed from inception at PureTech to FDA approval. The company's strategy focuses on unlocking the potential of validated biology by improving efficacy, enabling oral delivery, or enhancing tolerability.
View full company profileOther Undisclosed Drugs
| Drug | Company | Phase |
|---|---|---|
| ASPEN Study Program | Insmed | Phase 3 |
| ARISE Study Program | Insmed | Phase 3 |
| MGL-2086 | Madrigal Pharmaceuticals | Phase 1 |
| Innovative Proprietary/Licensed Products | Laboratorios Farmaceuticos Rovi | Various |
| Undisclosed Partnered Program | Septerna | Discovery |
| Undisclosed Cell Therapy | Immix Biopharma | Pre-clinical |
| HTL0039732 | Nxera Pharma | Preclinical |
| Bispecific (Undisclosed) | MacroGenics | Preclinical |
| Sec61 Portfolio Assets | Kezar Life Sciences | Preclinical |
| WTX-518 | Werewolf Therapeutics | Preclinical |
| WTX-712 | Werewolf Therapeutics | Preclinical |
| Measovir®-based Prophylactic Vaccine (with Unither) | Oncovita | Research/Pre-clinical |